Bronchoalveolar lavage and blood plasma samples from COVID-19 patients with diabetes can be obtained and analyzed to determine the relative levels of soluble ACE2, osteopontin, and furin present and can be compared to those in COVID-19 patients without diabetes, and healthy subjects. This evidence concerns the gene SPP1 and diabetes mellitus.